Selective anthelmintic therapy has been recommended as a sustainable strategy for cyathostomin control in horse populations for several decades. The traditional approach has been to determine strongyle fecal egg counts (FEC) for all horses, with treatment only recommended for those exceeding a predetermined threshold. The aims are to achieve a reduction of overall egg shedding, while leaving a proportion of the herd untreated, which lowers anthelmintic treatment intensity and reduces selection pressure for development of anthelmintic resistance. This study made use of the cyathostomin model to evaluate the influence of treatment strategies with between 1 and 8 yearly treatment occasions, where either 1) all horses were treated, 2) a predetermined proportion of the herd remained untreated, or 3) horses were treated if their FEC exceeded thresholds between 100 and 600 strongyle eggs per gram. Weather data representing four different climatic zones was used and three different herd age structures were compared; 1) all yearlings, 2) all mature horses 10–20 years old, and 3) a mixed age structure of 1–20 years of age. Results indicated a consistent effect of age structure, with anthelmintic resistance developing quickest in the yearling group and slowest among the mature horses. Development of anthelmintic resistance was affected by treatment intensity and selective therapy generally delayed resistance. Importantly, the results suggest that the effects of selective therapy on resistance development are likely to vary between climatic zones and herd age structures. Overall, a substantial delaying of resistance development requires that the average number of treatments administered annually across a herd of horses needs to be about two or less. However, results also indicate that an age-structured prioritisation of treatment to younger horses should still be effective. It appears that a ‘one-size-fits-all’ approach to the management of anthelmintic resistance in cyathostomins is unlikely to be optimal.
|Number of pages||7|
|Journal||International Journal for Parasitology: Drugs and Drug Resistance|
|State||Published - Aug 2019|
Bibliographical noteFunding Information:
This work was instigated and initially funded by a grant from Zoetis LLC, USA ( IND4941 ). It continues with funding from AgResearch SSIF, New Zealand ( A22701 ). The University of Kentucky , Department of Veterinary Science Clay Fellowship Fund supported Dr. Nielsen's sabbatical at AgResearch in New Zealand in 2018.
This work was instigated and initially funded by a grant from Zoetis LLC, USA (IND4941). It continues with funding from AgResearch SSIF, New Zealand (A22701). The University of Kentucky, Department of Veterinary Science Clay Fellowship Fund supported Dr. Nielsen's sabbatical at AgResearch in New Zealand in 2018.
© 2019 The Authors
- Anthelmintic resistance
- Parasite control
ASJC Scopus subject areas
- Infectious Diseases
- Pharmacology (medical)